MILabs was founded in 2006 as a spin-off from the University Medical Centre Utrecht, the Netherlands. Today, a whole new line of highly reliable preclinical imaging systems has been developed with unsurpassed resolution, speed and sensitivity, and unprecedented multi-modal functionality. These instruments have received many international awards from the scientific community and support the research of many happy users worldwide. Hundreds of scientific papers have already been published to document the use of MILabs’ systems for important discoveries in many fields including pharmacology, oncology, cardiology, bone research, diabetes and neuroscience.
Unmatched quality through continuous improvements
MILabs achieved its first commercial success with the U-SPECT and U-SPECT/CT systems, which today deliver sub-quarter-mm resolution images of radiolabeled tracers. There has been a continuum of new developments that further improved the performance and functionality of MILabs imaging systems. In 2011, MILabs introduced VECTor, an extremely user-friendly, fully integrated simultaneous PET and SPECT imaging technology that provides uniform ultra-high resolution for PET as well as for SPECT. In addition, clinical SPECT systems with unmatched performance are currently being developed, for which MILabs received the 2015 Innovation of the Year award from the World Molecular Imaging Society. In 2015 MILabs launched U-CT, a best-in-class preclinical in vivo CT scanner, which provides unprecedented resolution, low dose imaging capabilities and outstanding scanning speed. Today U-CT units are integrated in the U-SPECT/CT, U-PET/CT and VECTor/CT systems. Most recently MILabs launched an optical imaging module for its preclinical systems. Customers can now order SPECT, PET, Optical Imaging and X-ray CT as single-modality systems or fully integrated in any combination on a multimodality imaging platform.
Latest technologies for arguably the best ever achieved imaging performance
MILabs systems are built in different base configurations to best meet the researcher’s application needs, offering exceptional performance, cost-effectiveness and extremely high reliability. Whether offered as stand-alone units or in hybrid configurations, MILabs is truly pushing the performance limits in terms of image quality and multi-modal functionality. With 0.15 mm SPECT and 0.6 mm PET resolution, nuclear imaging performance is currently approaching physical limits, set by the positron range for PET. Complemented by X-ray CT and Optical Imaging with unique autonomous operation on an integrated multi-modal platform, multimodality imaging is supported by a simple, intuitive and user-friendly operation to ensure highly efficient workflows, including single-pass PET, SPECT, Optical and CT imaging of small animals with a single dose of anesthesia.